{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Adolescence",
      "Depression",
      "Prediction",
      "Prevention",
      "Risk score",
      "Young adult"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "36029626",
  "DateCompleted": {
    "Year": "2022",
    "Month": "10",
    "Day": "18"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "22"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2022",
        "Month": "08",
        "Day": "20"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.jpsychires.2022.08.017",
      "S0022-3956(22)00470-8"
    ],
    "Journal": {
      "ISSN": "1879-1379",
      "JournalIssue": {
        "Volume": "155",
        "PubDate": {
          "Year": "2022",
          "Month": "Nov"
        }
      },
      "Title": "Journal of psychiatric research",
      "ISOAbbreviation": "J Psychiatr Res"
    },
    "ArticleTitle": "Identifying adolescents at risk for depression: Assessment of a global prediction model in the Great Smoky Mountains Study.",
    "Pagination": {
      "StartPage": "146",
      "EndPage": "152",
      "MedlinePgn": "146-152"
    },
    "Abstract": {
      "AbstractText": [
        "The Identifying Depression Early in Adolescence Risk Score (IDEA-RS) has been externally assessed in samples from four continents, but North America is lacking. Our aim here was to evaluate the performance of the IDEA-RS in predicting future onset of Major Depressive Disorder (MDD) in an adolescent population-based sample in the United States of America - the Great Smoky Mountains Study (GSMS). We applied the intercept and weights of the original IDEA-RS model developed in Brazil to generate individual probabilities for each participant of the GSMS at age 15 (N\u00a0=\u00a01029). We then evaluated the performance of such predictions against the diagnosis of MDD at age 19 using simple, case-mix corrected and refitted models. Furthermore, we compared how prioritizing the information provided by parents or by adolescents affected performance. The IDEA-RS exhibited a C-statistic of 0.63 (95% CI 0.53-0.74) to predict MDD in the GSMS when applying uncorrected weights. Case-mix corrected and refitted models enhanced performance to 0.69 and 0.67, respectively. No significant difference was found in performance by prioritizing the reports of adolescents or their parents. The IDEA-RS was able to parse out adolescents at risk for a later onset of depression in the GSMS cohort with above chance discrimination. The IDEA-RS has now showed above-chance performance in five continents."
      ],
      "CopyrightInformation": "Copyright \u00a9 2022 The Authors. Published by Elsevier Ltd.. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil; Child and Adolescent Psychiatry Division, Hospital de Cl\u00ednicas de Porto Alegre (HCPA), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil."
          }
        ],
        "LastName": "Caye",
        "ForeName": "Arthur",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil."
          }
        ],
        "LastName": "Marchionatti",
        "ForeName": "Lauro E",
        "Initials": "LE"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil; Child and Adolescent Psychiatry Division, Hospital de Cl\u00ednicas de Porto Alegre (HCPA), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil."
          }
        ],
        "LastName": "Pereira",
        "ForeName": "Rivka",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "King's College London, Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, London, United Kingdom; ESRC Centre for Society and Mental Health, King's College London, London, United Kingdom."
          }
        ],
        "LastName": "Fisher",
        "ForeName": "Helen L",
        "Initials": "HL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Global Mental Health, Department of Psychiatry, School of Medicine and Health Sciences, The George Washington University, Washington, DC, United States."
          }
        ],
        "LastName": "Kohrt",
        "ForeName": "Brandon A",
        "Initials": "BA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "King's College London, Department of Psychological Medicine, Institute of Psychiatry, Psychology, London, United Kingdom; National Institute for Health Research Mental Health Biomedical Research Centre, South London and Maudsley NHS Foundation Trust and King's College London, London, United Kingdom."
          }
        ],
        "LastName": "Mondelli",
        "ForeName": "Valeria",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "University of Vermont, Burlington, VT, United States."
          }
        ],
        "LastName": "McGinnis",
        "ForeName": "Ellen",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "University of Vermont, Burlington, VT, United States."
          }
        ],
        "LastName": "Copeland",
        "ForeName": "William E",
        "Initials": "WE"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil; Child and Adolescent Psychiatry Division, Hospital de Cl\u00ednicas de Porto Alegre (HCPA), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil. Electronic address: ckieling@ufrgs.br."
          }
        ],
        "LastName": "Kieling",
        "ForeName": "Christian",
        "Initials": "C"
      }
    ],
    "GrantList": [
      {
        "GrantID": "K23 MH123031",
        "Acronym": "MH",
        "Agency": "NIMH NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R21 MH124072",
        "Acronym": "MH",
        "Agency": "NIMH NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "MC_PC_MR/R019460/1",
        "Acronym": "MRC_",
        "Agency": "Medical Research Council",
        "Country": "United Kingdom"
      },
      {
        "Acronym": "DH_",
        "Agency": "Department of Health",
        "Country": "United Kingdom"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "J Psychiatr Res",
    "NlmUniqueID": "0376331",
    "ISSNLinking": "0022-3956"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Disaccharides"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Glucuronates"
    },
    {
      "RegistryNumber": "98632-68-9",
      "NameOfSubstance": "O-(glucuronic acid 2-sulfate)-(1--4)-O-(2,5)-anhydromannitol 6-sulfate"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cohort Studies"
    },
    {
      "QualifierName": [
        "diagnosis",
        "epidemiology"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "diagnosis",
        "epidemiology"
      ],
      "DescriptorName": "Depressive Disorder, Major"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disaccharides"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Glucuronates"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Young Adult"
    }
  ],
  "CoiStatement": "Declaration of competing interest AC has acted as a consultant for Knight Therapeutics in the past year. VM has received research funding from Johnson & Johnson. All other authors declare no competing interests."
}